Netherlands · Biotechnology startup
Netherlands · DCPrime
DCPrime is a clinical stage company which develops novel cancer immunotherapies based on its DCOne platform technology.
Funding reportedLast round: Undisclosed round
What company datasets say DCPrime raised
Funding, as reported
Reported in all22.2Min the source's currency
Rounds5
Last roundUndisclosed round
Last round dateMar 2018
Investors listed4
Biotechnology in Netherlands
Startups like it
Is this your company?
Add your raise, your deck and your story, and put DCPrime in front of investors. Or tell us what we have wrong.